- UroToday Home
- Center Of Excellence
Centers of Excellence
The Latest Research on mHSPC
Curated by clinicians: educational forums with videos, abstracts and conference information
Alicia Morgans, MD, MPH is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. She is a clinician and physician investigator specializing is investigating complications of systemic therapy for prostate cancer survivors. She has expertise in clinical trials and patient reported outcome measures, and as well as incorporating patient preferences and beliefs into clinical decision making.
Conference Coverage
Recent data from conferences worldwide
EAU 2019 Prostate Cancer
ESMO 2018 Prostate Cancer
- ESMO 2018: Randomized Trial of Androgen Deprivation Therapy + Enzalutamide Versus ADT + Bicalutamide in Metastatic Hormone Sensitive Prostate Cancer October 23, 2018
ASCO 2018 Prostate Cancer
- ASCO 2018: Treatment of Metastatic Hormone-Sensitive Prostate Cancer and Implications for Subsequent Management June 20, 2018
ASCO GU 2018 Prostate Cancer
Abstracts
An extensive resource of papers on urological diseases and conditions
- Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
- Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
E-Newsletters
Free Daily and Weekly newsletters offered by content of interest
The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.